Oruka Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Other Operating Assets of $224.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2015-08-11
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2014-12-31 was $93.00K, a 210.00% increase year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2014-09-30 was -$249.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2014-06-30 was $3.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2014-03-31 was $698.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2014 was $545.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2013 was -$14.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2012 was -$80.00K.
- Oruka Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2011 was -$80.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 117 month | Increase (Decrease) in Other Operating Assets 120 month | Increase (Decrease) in Other Operating Assets 123 month | Increase (Decrease) in Other Operating Assets 126 month | Increase (Decrease) in Other Operating Assets 129 month | Increase (Decrease) in Other Operating Assets 132 month | Increase (Decrease) in Other Operating Assets 135 month | Increase (Decrease) in Other Operating Assets 138 month | Increase (Decrease) in Other Operating Assets 141 month | Increase (Decrease) in Other Operating Assets 144 month | Increase (Decrease) in Other Operating Assets 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | $224.00K 10-Q · filed 2015-08-11 | ||||||||||||||
| 2014-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | -$156.00K derived: sum of 2 quarters · filed 2015-03-19 | -$153.00K derived: sum of 3 quarters · filed 2015-08-11 | $545.00K 10-K · filed 2015-03-19 | |||||||||||
| 2014-09-30 | -$249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$246.00K derived: sum of 2 quarters · filed 2015-08-11 | $452.00K 10-Q · filed 2014-11-12 | $482.00K derived: sum of 4 quarters · filed 2015-08-11 | |||||||||||
| 2014-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $701.00K 10-Q · filed 2015-08-11 | $731.00K derived: sum of 3 quarters · filed 2015-08-11 | $727.00K derived: sum of 4 quarters · filed 2015-08-11 | |||||||||||
| 2014-03-31 | $698.00K 10-Q · filed 2015-05-12 | $728.00K derived: sum of 2 quarters · filed 2015-05-12 | $724.00K derived: sum of 3 quarters · filed 2015-05-12 | $704.00K derived: sum of 4 quarters · filed 2015-05-12 | -$6.64M 10-Q · filed 2014-05-13 | ||||||||||
| 2013-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $26.00K derived: sum of 2 quarters · filed 2015-03-19 | $6.00K derived: sum of 3 quarters · filed 2015-03-19 | -$14.00K 10-K · filed 2015-03-19 | -$7.34M 10-K · filed 2014-03-20 | ||||||||||
| 2013-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$24.00K derived: sum of 2 quarters · filed 2014-11-12 | -$44.00K 10-Q · filed 2014-11-12 | -$64.00K derived: sum of 4 quarters · filed 2014-11-12 | -$7.37M 10-Q · filed 2013-11-13 | ||||||||||
| 2013-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$40.00K 10-Q · filed 2014-08-13 | -$60.00K derived: sum of 3 quarters · filed 2014-08-13 | -$80.00K derived: sum of 4 quarters · filed 2014-08-13 | -$7.37M 10-Q · filed 2013-08-13 | ||||||||||
| 2013-03-31 | -$20.00K 10-Q · filed 2014-05-13 | -$40.00K derived: sum of 2 quarters · filed 2014-05-13 | -$60.00K derived: sum of 3 quarters · filed 2014-05-13 | -$80.00K derived: sum of 4 quarters · filed 2014-05-13 | -$7.35M 10-Q · filed 2013-05-13 | ||||||||||
| 2012-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$40.00K derived: sum of 2 quarters · filed 2014-03-20 | -$60.00K derived: sum of 3 quarters · filed 2014-03-20 | -$80.00K 10-K · filed 2014-03-20 | -$7.33M 10-K · filed 2013-03-21 | ||||||||||
| 2012-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$40.00K derived: sum of 2 quarters · filed 2013-11-13 | -$60.00K 10-Q · filed 2013-11-13 | -$80.00K derived: sum of 4 quarters · filed 2013-11-13 | -$7.31M 10-Q · filed 2012-11-13 | ||||||||||
| 2012-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$40.00K 10-Q · filed 2013-08-13 | -$60.00K derived: sum of 3 quarters · filed 2013-08-13 | -$80.00K derived: sum of 4 quarters · filed 2013-08-13 | -$7.29M 10-Q · filed 2012-08-13 | ||||||||||
| 2012-03-31 | -$20.00K 10-Q · filed 2013-05-13 | -$40.00K derived: sum of 2 quarters · filed 2013-05-13 | -$60.00K derived: sum of 3 quarters · filed 2013-05-13 | -$80.00K derived: sum of 4 quarters · filed 2013-05-13 | -$7.27M 10-Q · filed 2012-05-14 | ||||||||||
| 2011-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | -$40.00K derived: sum of 2 quarters · filed 2013-03-21 | -$60.00K derived: sum of 3 quarters · filed 2013-03-21 | -$80.00K 10-K · filed 2013-03-21 | -$7.25M 10-K · filed 2012-03-27 | ||||||||||
| 2011-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$40.00K derived: sum of 2 quarters · filed 2012-11-13 | -$60.00K 10-Q · filed 2012-11-13 | -$7.23M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$40.00K 10-Q · filed 2012-08-13 | |||||||||||||
| 2011-03-31 | -$20.00K 10-Q · filed 2012-05-14 | ||||||||||||||
| 2010-12-31 | -$84.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |